Breast Cancer Patient Equity Act

Breast Cancer Patient Equity Act

This bill provides for Medicare coverage of custom fabricated breast prostheses following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses. Currently, Medicare covers surgically implanted breast prostheses, as well as some external breast prostheses (e.g., post-surgical bras).

The Breast Cancer Patient Equity Act, also known as Bill 118 hr 4779, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to ensure that breast cancer patients have access to necessary treatments and services without facing financial barriers.

One key provision of the bill is to require insurance companies to cover breast cancer treatments, including surgeries, chemotherapy, and radiation therapy, at the same level as other medical conditions. This would prevent patients from being denied coverage or facing high out-of-pocket costs for their care.

Additionally, the Breast Cancer Patient Equity Act aims to improve access to clinical trials for breast cancer patients. By requiring insurance companies to cover the costs associated with participating in clinical trials, more patients would have the opportunity to access cutting-edge treatments and potentially life-saving therapies. Overall, the goal of Bill 118 hr 4779 is to ensure that breast cancer patients receive equitable and affordable care, regardless of their insurance coverage. This legislation is important in addressing the financial burdens that many patients face when seeking treatment for this serious and often life-threatening disease.